Stiplastics Healthcaring

Jérôme Empereur - Stiplastics Healthcaring’s Chairman-CEO

Company profile

Stiplastics Healthcaring (founded in 1985) designs, develops and manufactures standard and smart plastic solutions for the pharmaceutical industries and the health sector. Based in Saint-Marcellin (Isère - France), the company currently employs over 90 people on a 10,000 m2 industrial site opened last October. The Group expects to achieve turnover of EUR 21 million in the current 2017/2018 financial year, 98% of which will be generated by the health sector. Exports account for 55% of Stiplastics’ turnover, thanks to its development of devices for the dispensing of solid-form medications (especially in the USA).

Investment rationale

The company has a strong development potential in the connected health sector, with new products in the pipeline and a modern workshop for the production of electronic products in a controlled environment. In order to meet the new needs of patients and healthcare actors faced with changing pathologies and uses, and more specifically the increasing prominence of connected care, the Group has set up its IoC [Internet Of Care]® unit, which is dedicated to designing, developing and producing e-health medical devices. In addition, several partnership agreements were finalised in 2017 in what is an extremely promising sector, which will benefit patients and practitioners alike.  Mérieux Développement and Gimv (joint investment by Gimv and the Gimv Health & Care fund​) have joined forces to acquire Stiplastics Healthcaring.

Growth strategy

The Mérieux Développement-Gimv consortium will contribute its complementary expertise in the health sector and support the growth of this French company.

Stiplastics Healthcaring

Benoit Chastaing, Partner

Benoit joined Gimv's Health & Care team in 2016. Before Benoit was Head of M&A and IR at Medipole Partenaires Group (the 3rd largest private healthcare organizations in the territory with 55 care centers). As such, he was member of the Executive Committee of the group. He joined the management team of Medipole Partenaires in 2007. He directed many high level operations for the Group (acquisition, LBO operation, bond financing, etc.). In 2013, Benoit was a leader in one of the largest transactions of the sector (€1.1 billion): the merge of Médi-Partenaires and Medipole Sud Santé to give rise to the third largest health group in France.

Prior to joining Medipole Partenaires, Benoit worked at PwC as an auditor, then joined Rexel where he held several responsibilities both in France and abroad, most recently as Chief Financial Officer of southern Europe.
He graduated from ESCEM and the IMD Lausanne. Former auditor of IHEDN (66th SN), He is also a reservist in the French Navy (Lieutenant Commander).


+33 1 58 36 45 77

83, rue Lauriston
75116 Paris


Benoit Chastaing